Dissertation > Excellent graduate degree dissertation topics show

A Clinical Study of Lamivudine and Adefovir Dipivoxil in the Treatment of Decompensated Cirrhosis Resulting from Chronic Hepatitis B

Author: QiJingHu
Tutor: ShiXiaoFeng
School: Chongqing Medical University
Course: Internal Medicine
Keywords: Hepatitis B cirrhosis decompensated lamivudine adefovir dipivoxil
CLC: R512.62
Type: Master's thesis
Year: 2011
Downloads: 55
Quote: 0
Read: Download Dissertation

Abstract


Objective:To evaluate and compare the clinical efficacy and safety of lamivudine(LAM) and adefovir dipivoxil(ADV) in the treatment of decompensated cirrhosis resulting from hepatitis B,and to discuss the remedy strategy for the resistance.Methods:The retrospective study data were collected from consecutive patient’s files. All patients were hepatitis B relative decompensated cirrhosis, LAM group,patients treated with 100mg of lamivudine daily,and ADV group, patients treated with 10mg of adefovir dipivoxil daily,and no antiviral treatment group. To sort and analyse the following variables:age, sex,liver biochemistry,prothrombintime,HBVDNAlevel,HBeAg/HBeAb,Child-Pugh,abdominal ultrasound,changes of the clinical symptoms and signs,adverse drug reactions and so on.Result:Statistical analysis the above data at the months 6,12,18 and 24 respectively. With the extension of treatment, the clinical symptoms and signs of LAM and ADV groups were improved obviously. A significant improvement was observed in ALT, ALB, TBIL,PT and Child-Pugh of LAM and ADV groups compared to baseline and no-antiviral group(P<0.05),but there was no significant difference between LAM and ADV groups.The serum HBV-DNA normalization rate and HBeAg normalization rate were superior to no-antiviral group,but there was no significant difference between LAM and ADV groups.The rate of virologic breakthrough in the LAM group were 15.4% and 25.0%,which were detected within12 months and 24 months respectively; the counterpart to ADV group were 2.4% and 6.9%,which have statistically significant between two groups.For these patients had virologic breakthrough can obtain good effect with combination lamivudine and adefovir dipivoxil for treatment.No patient in the LAM and ADV groups developed obvious adverse reactions throughout the course of treatment.There was no significant difference in side effects in both groups.Conclusions:Lamivudine and Adefovir dipivoxil have better efficacy and security in the antiviral treatment of decompensated cirrhosis resulting from hepatitis B,but the ratio of virus-resistant mutation was lower in adefovir dipivoxil group.Combination therapy(LAM and ADV) was effective for LAM-resistant or ADV-resistant.

Related Dissertations

  1. Study on Correlation between TCM Syndrome Types and IFN-γ in Patients with Chronic Hepatitis B,R259
  2. Retrospective Study on Pathological Results, Four Results of Liver Fiber, and TCM Syndrome Type of 164 CHB Patients,R259
  3. The Relationship between Plasma B-type Natriuretic Peptide and Liver Function in Patients with Cirrhosis,R575.2
  4. Clinical Research of Autologous Bone Marrow Stem Cell Transplantation on Liver Cirrhosis Induced by Hepatitis B,R575.2
  5. Retrospective Analysis of Infectious Precipitating Factors in Cirrhosis with Hepatic Encephalopathy,R575.2
  6. The Curative Effects of 72-week Entecavir Therapy for Patients with Decompensated Hepatitis B Virus-Related Cirrhosis,R512.62
  7. Relationship and Significance of Gene Transcription Profiles in Rat Liver Regeneration and Liver Cirrhosis Occurrence,R575.2
  8. Preliminary Investigation of Research Intestinal Microflora in Patients with Hepatic Cirrhosis by FISH and LCSM,R575.2
  9. The Value of MELD Score and Serum Total Cholesterol in Predicting the Prognsis of Patients with Decompensated Liver Cirrhosis Caused by Hepatitis B Virus,R575.2
  10. Serum Cholinesterase, Platelet, Liver Fibrosis HBV Infection in Various Stages of Clinical Significance,R575.2
  11. The Results of Endoscopic Variceal Ligation of Esophageal Varices and the Effect on Haemodynamics of Portal Systom,R575.2
  12. Clinical Research of Autologous Bone Marrow Stem Cell Transplantation for Treatment of Decompensated in Cirrhosis,R575.2
  13. The Discussion of the Relationship between Plasma B-type Natriuretic Peptide and Ascites , Output of Urine Potassium and Natrium in Patients with Cirrhosis,R575.2
  14. Clinical Study on Decompensation in Liver Cirrhosis and Establishment of Relevant Network Database,R575.2
  15. PSE lamivudine hepatitis B cirrhosis and portal hypertension clinical observation,R575.2
  16. Edaravone , lamivudine , pharmaceutical intermediates research and development,TQ463.5
  17. The Characteristic of the Whole Hepatitis B Virus Gene, Construction of HBV Gene Eukaryotic Cell Expression Vector, and the Efficacy of Adefovir Plus Entecavir or Plus Lamivudine as Rescue Therapies in Chronic Hepatitis B Patients with Entecavir-resistant,R512.62
  18. Aanalysis of Genotype and ORF3 Gene Mutation of Hepatitis E Virus in Wuhan,R512.6
  19. Cytokines Expression in Hepatitis B Virus X Gene Hydrodynamic Injection Mouse Model and the Construction of GST-MIG, GST-IP10 Recombined Protokaryon Vector,Q78
  20. Rescue Therapy for Lamivudine-failured Chronic Hepatitis B: Comparison Therapeutic Effect,R512.62
  21. Yinchen Wuling Powder’s Increasing Herbal Medicine Through Colon Dialysis to Treat Chronic for Hepatitis B Syndrome of Dampness-heat Stagnating in Spleen Clinical Observation,R259

CLC: > Medicine, health > Internal Medicine > Infectious disease > Viral infections > Viral Hepatitis > Hepatitis B
© 2012 www.DissertationTopic.Net  Mobile